Outcomes of lowered newborn screening thresholds for congenital hypothyroidism
Journal of Paediatrics and Child Health · 2023
DOI: 10.1111/jpc.16425 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Paediatrics and Child Health, 2023. Verfasst von Aolei Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Neonatal Screening, Congenital Hypothyroidism, Thyrotropin. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Newborn screening (NBS) has largely eliminated the physical and neurodevelopmental effects of untreated congenital hypothyroidism (CH). Many countries, including Australia, have progressively lowered NBS bloodspot thyroid‐stimulating hormone (b‐TSH) thresholds. The impact of these changes is still unclear.
Objectives
To evaluate the performance of CH NBS following the reduction of b‐TSH thresholds in New South Wales (NSW) and the Australian Capital Territory (ACT), Australia, from 15 to 8 mIU/L, and to determine the clinical outcomes of cases detected by these thresholds.
Methods
NBS data of 346 849 infants born in NSW/ACT, Australia from 1 November, 2016–1 March, 2020 inclusive were analysed. A clinical audit was conducted on infants with a preliminary diagnosis of CH born between 1 January, 2016–1 December, 2020 inclusive.
Results
The lowered b‐TSH threshold (≥8 mIU/L, ~99.5th centile) detected 1668 infants (0.48%), representing an eight‐fold increase in recall rate, of whom 212 of 1668 (12.7%) commenced thyroxine treatment. Of these 212 infants, 62 (29.2%) (including eight cases with a preliminary diagnosis of thyroid dysgenesis) had an initial b‐TSH 8–14.9 mIU/L. The positive predictive value for a preliminary diagnosis of CH decreased from 74.3% to 12.8% with the lowered threshold. Proportionally, more pre‐term infants received a preliminary CH diagnosis on screening with the lower threshold (16.1% of 62) than with the higher threshold (8.0% of 150).
Conclusion
Clinically relevant CH was detected using the lowered threshold, albeit at the cost of an eight‐fold increase in recall rate. Further clinical and economic studies are required to determine whether benefits of lowered screening thresholds outweigh potential harms from false‐positive results on infants, their families and NBS programs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
- Child Population and Translational Health Research, Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
- New South Wales Newborn Screening Program, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.
- Disciplines of Genetic Medicine and Paediatrics and Child Health, University of Sydney, Sydney, New South Wales, Australia.
- University Centre for Rural Health, Lismore, NSW 2480, University of Sydney, Lismore, Australia, Australia.
ORCID-Profile: Aolei Yu, Michelle Jack
Zitieren
APA
Yu, A., Alder, N., Lain, S. J., Wiley, V., Nassar, N., & Jack, M. (2023). Outcomes of lowered newborn screening thresholds for congenital hypothyroidism. Journal of Paediatrics and Child Health. https://doi.org/10.1111/jpc.16425
Vancouver
Yu A, Alder N, Lain SJ, Wiley V, Nassar N, Jack M. Outcomes of lowered newborn screening thresholds for congenital hypothyroidism. Journal of Paediatrics and Child Health. 2023. doi:10.1111/jpc.16425
BibTeX
@article{Yu2023,
author = {Yu, Aolei and Alder, Nelson and Lain, Samantha J and Wiley, Veronica and Nassar, Natasha and Jack, Michelle},
title = {Outcomes of lowered newborn screening thresholds for congenital hypothyroidism},
journal = {Journal of Paediatrics and Child Health},
year = {2023},
doi = {10.1111/jpc.16425}
}
EUVIMED